BPC-157 / TB-500 5+5mg Mix
Pre-mixed dual-peptide blend of BPC-157 and TB-500 at equimolar concentrations (5 mg + 5 mg). Designed for research protocols exploring synergistic tissue repair mechanisms across complementary regenerative pathways.
69,99 €
≥99% HPLC purityThird-party tested · Discreet packaging · Ships from the EU
Specifications
- SKU
- BPC157-TB500-MIX
Usage Notes
This compound is intended exclusively for in vitro research. Refer to peer-reviewed literature for dosing protocols and experimental methodologies.
Disclaimer: Not for human or animal consumption. Not approved by EMA or FDA.
BPC-157 / TB-500 5+5mg Mix
Research profile
Overview
This formulation combines BPC-157 and TB-500 in a single lyophilised vial at equal concentrations (5 mg each). Both compounds target complementary mechanisms in tissue repair, and their co-administration is a widely studied model for synergistic regenerative effects.
Rationale for Combination Research
-
Complementary Mechanisms
BPC-157 acts primarily through the NO-system and VEGF upregulation; TB-500 targets actin dynamics and satellite cell activation. Together they address multiple phases of tissue repair simultaneously. -
Overlapping Angiogenic Targets
Both peptides independently promote angiogenesis and fibroblast activity, with research suggesting additive effects in musculoskeletal injury models. -
Connective Tissue Models
Particularly studied in tendon, ligament, and cartilage repair protocols where both vascularisation and structural matrix deposition are critical endpoints.
Specifications
| BPC-157 content | 5 mg (CAS 137525-51-0) |
|---|---|
| TB-500 content | 5 mg (CAS 77591-33-4) |
| Combined purity | ≥99% per component (HPLC verified) |
| Form | Lyophilised powder blend |
For in vitro laboratory research use only. Not for human or animal administration.
Reviews
There are no reviews yet.